BRPI0515040B1 - Géis de testosterona compreendendo propileno glicol como intensificador de penetração - Google Patents

Géis de testosterona compreendendo propileno glicol como intensificador de penetração Download PDF

Info

Publication number
BRPI0515040B1
BRPI0515040B1 BRPI0515040-0A BRPI0515040A BRPI0515040B1 BR PI0515040 B1 BRPI0515040 B1 BR PI0515040B1 BR PI0515040 A BRPI0515040 A BR PI0515040A BR PI0515040 B1 BRPI0515040 B1 BR PI0515040B1
Authority
BR
Brazil
Prior art keywords
testosterone
pharmaceutical composition
gelling agent
propylene glycol
gel
Prior art date
Application number
BRPI0515040-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Dominique Salin-Drouin
Original Assignee
Besins Healthcare Luxembourg S.A.R.L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292170A external-priority patent/EP1634583A1/en
Application filed by Besins Healthcare Luxembourg S.A.R.L filed Critical Besins Healthcare Luxembourg S.A.R.L
Publication of BRPI0515040A publication Critical patent/BRPI0515040A/pt
Publication of BRPI0515040B1 publication Critical patent/BRPI0515040B1/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
BRPI0515040-0A 2004-09-09 2005-09-07 Géis de testosterona compreendendo propileno glicol como intensificador de penetração BRPI0515040B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04292170.0 2004-09-09
EP04292170A EP1634583A1 (en) 2004-09-09 2004-09-09 Testosterone gels comprising propylene glycol as penetration enhancer
US63836004P 2004-12-23 2004-12-23
US60/638,360 2004-12-23
PCT/EP2005/010293 WO2006027278A1 (en) 2004-09-09 2005-09-07 Testosterone gels comprising propylene glycol as penetration enhancer

Publications (2)

Publication Number Publication Date
BRPI0515040A BRPI0515040A (pt) 2008-07-01
BRPI0515040B1 true BRPI0515040B1 (pt) 2021-10-13

Family

ID=39381985

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515040-0A BRPI0515040B1 (pt) 2004-09-09 2005-09-07 Géis de testosterona compreendendo propileno glicol como intensificador de penetração

Country Status (6)

Country Link
JP (1) JP2008512425A (enExample)
BR (1) BRPI0515040B1 (enExample)
EA (1) EA013430B1 (enExample)
IL (1) IL181583A0 (enExample)
MX (1) MX2007002814A (enExample)
NZ (1) NZ553446A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
CN107949389A (zh) * 2015-09-30 2018-04-20 富士胶片株式会社 经皮吸收用组合物
JP7220473B2 (ja) * 2017-10-30 2023-02-10 帝國製薬株式会社 経皮投与製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
HRP20030510A2 (en) * 2000-12-22 2005-04-30 Dr. August Wolff Gmbh & Co. Arzneimittel Gel composition and trans-scrotal application of acomposition for the treatment of hypogonadism
EP1317921B1 (fr) * 2001-12-07 2009-08-19 Besins International Belgique Composition pharmaceutique sous forme de gel ou de solution à base de dihydrotestostérone, son procédé de préparation et ses utilisations
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition

Also Published As

Publication number Publication date
MX2007002814A (es) 2007-05-16
HK1099887A1 (en) 2007-08-24
JP2008512425A (ja) 2008-04-24
EA200700580A1 (ru) 2007-08-31
IL181583A0 (en) 2007-07-04
EA013430B1 (ru) 2010-04-30
BRPI0515040A (pt) 2008-07-01
NZ553446A (en) 2010-05-28

Similar Documents

Publication Publication Date Title
NO341780B1 (no) Testosterongeler omfattende polypropylenglykol og isopropylmyristat som gjennomtrengningsforsterker
US8486925B2 (en) Testosterone gel and method of use
TWI283579B (en) Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta-diol
JP5727494B2 (ja) 活性剤を含む経皮医薬組成物
TWI564029B (zh) 睪固酮調配物
PT1322336E (pt) Método de aumentar as concentrações de testosterona e esteróides relacionados em mulheres
BRPI0720945A2 (pt) instrumento espalhador
EA009839B1 (ru) Фармацевтическая композиция для усиления трансдермальной доставки андрогена и способы ее применения
CN101217874A (zh) 治疗或预防骨退化或骨质疏松症的方法
NZ553446A (en) Testosterone gels comprising propylene glycol as penetration enhancer
HK1099887B (en) Testosterone gels comprising propylene glycol and isopropyl myristate as penetration enhancers
BRPI0518139B1 (pt) Formulações de gel de 4-hidróxi tamoxifeno

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU)

B25G Requested change of headquarter approved

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2899 DE 28/07/2026 POR TER SIDO INDEVIDA.